TransMedics: Q4 Earnings Snapshot

SelfRugger · 2026-03-16T10:30:20+00:00

TransMedics reported fourth-quarter earnings of $105.4 million, exceeding Wall Street's expectations. The company's net income was $2.62 per share, and annual revenue reached $605.5 million, with a forecast of $727-$757 million for the next year.

SelfRugger

2026-03-16 10:30:20

Abstract generation in progress

TransMedics: Q4 Earnings Snapshot

Associated Press Finance

Wed, February 25, 2026 at 6:45 AM GMT+9 1 min read

In this article:

TMDX

+2.32%

ANDOVER, Mass. (AP) — ANDOVER, Mass. (AP) — TransMedics Group Inc. (TMDX) on Tuesday reported fourth-quarter earnings of $105.4 million.

On a per-share basis, the Andover, Massachusetts-based company said it had net income of $2.62. Earnings, adjusted for pretax gains, were 57 cents per share.

The results topped Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of 41 cents per share.

The medical technology company posted revenue of $160.8 million in the period, which also topped Street forecasts. Six analysts surveyed by Zacks expected $155.9 million.

For the year, the company reported profit of $190.3 million, or $4.87 per share. Revenue was reported as $605.5 million.

TransMedics expects full-year revenue in the range of $727 million to $757 million.

This story was generated by Automated Insights () using data from Zacks Investment Research. Access a Zacks stock report on TMDX at

Terms and Privacy Policy

Privacy Dashboard

More Info

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.